BRIEF published on 05/06/2026 at 15:36, 4 months 4 days ago Vanguard Discloses Stake in Intertek Group plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Intertek Group
BRIEF published on 05/06/2026 at 15:36, 4 months 4 days ago Vanguard révèle sa participation dans Intertek Group plc Code De Prise De Contrôle Le Groupe Vanguard Formulaire 8.3 Information Sur Les Valeurs Mobilières Groupe Intertek
BRIEF published on 05/06/2026 at 15:36, 4 months 4 days ago Vanguard Group Discloses Stake in International Personal Finance Vanguard Group Shareholding Disclosure UK Takeover Code Rule 8.3 Compliance International Personal Finance
BRIEF published on 05/06/2026 at 15:36, 4 months 4 days ago Le groupe Vanguard révèle sa participation dans la finance personnelle internationale Groupe Vanguard Finances Personnelles Internationales Déclaration Relative À L'actionnariat Code Des OPA Britannique Conformité À La Règle 8.3
BRIEF published on 05/06/2026 at 15:35, 4 months 4 days ago The Vanguard Group Discloses New Position in Gamma Communications The Vanguard Group Takeover Code Securities Disclosure Financial Regulations Gamma Communications
BRIEF published on 05/06/2026 at 15:35, 4 months 4 days ago Le groupe Vanguard annonce une nouvelle participation dans Gamma Communications Réglementation Financière Code De Prise De Contrôle Le Groupe Vanguard Information Sur Les Valeurs Mobilières Communications Gamma
BRIEF published on 05/06/2026 at 15:34, 4 months 4 days ago Vanguard Group Discloses Position in DCC Plc Irish Takeover Panel Vanguard Group Shareholding Equity Interests DCC Plc
BRIEF published on 05/06/2026 at 15:34, 4 months 4 days ago Vanguard Group révèle sa position dans DCC Plc Actionnariat Groupe Vanguard Participations En Actions Panel Irlandais Des OPA DCC Plc
BRIEF published on 05/06/2026 at 15:33, 4 months 4 days ago Vanguard Group Discloses Position in Bluefield Solar Income Fund Form 8.3 Takeover Code Vanguard Group Shares Transaction Bluefield Solar
BRIEF published on 05/06/2026 at 15:33, 4 months 4 days ago Le groupe Vanguard révèle sa participation dans le fonds Bluefield Solar Income. Groupe Vanguard Code De Prise De Contrôle Transaction D'actions Formulaire 8.3 Bluefield Solar
Published on 09/11/2026 at 04:00, 7 hours 43 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 18 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 23 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 43 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:35, 7 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 13 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 1 hour 27 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 2 hours 22 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 37 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 07:00, 4 hours 43 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 43 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 43 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 13 minutes ago Availability of the 2026 Interim Financial Report
